Overview
Updated: Aug 7, 2026
Company Overview
De novo Biotherapeutics
Next-generation cancer therapy by delivering multi-specific antibody encoded mRNAs in lipid nanoparticles
Address
Headquarters :S-Tower 17F, Saemunan-ro 82, Jongno-gu, Seoul, Republic of Korea, 03185
Research Center :-
Class
PharmaceuticalPartnering Goals
Private